The policing of lockdown places the entire population at the centre of a huge public order operation. The public they once protected from threats has itself become the threat.
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
It’s hard to eat while wearing a face mask, and social distancing isn’t easy in restaurants’ normally tight quarters. An infectious disease expert offers some tips on what to look for to stay safe.
The US president has reignited controversy over the use of malaria drugs to guard against COVID-19. But there is little reliable evidence so far that this tactic is safe or effective.
The government’s emergency relief package for childcare centres has kept many from collapsing financially due to COVID-19. The transition to other arrangements must be slow and carefully managed.
Immunity passports have been touted as a way to reopen the economy. But there are serious concerns they’ll create an incentive to intentionally contract the coronavirus.
Four decades on, and commencing retirement, Australians who entered the labour market during the 1970s recession are less happy than those born earlier or later.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand